The Stability Chamber is deployed across a diverse set of Indian industrial and commercial contexts. What follows is a set of expert application briefs prepared by our engineering team, each describing the operating problem, the applicable Indian and international standards, and how Ozmist's configuration is engineered to meet it.
Every application description references peer-reviewed research or a named regulatory standard so procurement teams, quality engineers, and plant managers can validate the claims against their own audit expectations. Sources are cited in the References section at the end of this page. If your application does not match one of the profiles below, contact our engineering team via the quote form — the majority of custom Ozmist installations begin with a spec conversation rather than a datasheet pick.
ICH Q1A(R2) Long-Term Stability Studies
Pharmaceutical R&D and QA · ICH Q1A(R2); WHO GMP
Long-term stability at 25°C / 60% RH or 30°C / 65% RH (Zone I/II) and 30°C / 75% RH (Zone IVB, India) supports the primary shelf-life claim in regulatory dossiers. Studies run 12–60 months with sampling at defined intervals. Stability chamber excursions during the study can invalidate the data set — the chamber must be reliable, alarmed, and calibrated. Ozmist chambers with redundant sensors and audit-trail data logging meet Indian pharmacopoeia and CDSCO expectations, and support ANDA / DMF filings to global markets.
Accelerated Stability Studies
Formulation R&D · ICH Q1A(R2)
Accelerated stability at 40°C / 75% RH runs for 6 months and provides an early indicator of product stability under stress. Failure modes — tablet dissolution shifts, colour drift, impurity growth, moisture uptake in blister-packed products — often show up here first. Fast-turn R&D uses accelerated data to screen formulation candidates. Ozmist chambers with high-accuracy control and fast-recovery from door openings support the intensive sampling schedules typical of formulation R&D.
Photostability Testing (with UV / VIS Attachment)
Pharma / cosmetics R&D · ICH Q1B
ICH Q1B requires photostability testing under specified UVA / VIS exposure with temperature and humidity controlled to avoid confounding thermal degradation. Ozmist supplies a photostability variant with fluorescent UV + visible light banks, actinometry-verified radiant exposure, and 25°C / 60% RH background environment. Used by pharma R&D and cosmetics stability groups.
Biological Product and Vaccine Stability
Biotech / vaccines · ICH Q5C
Vaccine and biological product stability testing at 2–8°C, 25°C / 60% RH, or 30°C / 65% RH supports regulatory submissions and shelf life claims. Excursion monitoring is particularly critical for biologicals because degradation is irreversible. Ozmist supplies vaccine developers and biologics manufacturers with chambers featuring extra-tight sensor redundancy, dual power supply, and 24-hour battery backup for the data logger.
Nutraceutical and Herbal Product Stability
Nutraceutical / Ayush · FSSAI Nutraceutical Regulation 2022; Ayush GMP
FSSAI and Ayush regulations increasingly require documented stability data for nutraceutical and Ayurvedic proprietary products. Stability at ICH accelerated conditions (40°C / 75% RH) for 6 months is a common minimum. Ozmist chambers, in mid-size 400 L or 800 L capacity, are cost-effective for nutraceutical stability programs and supply documentation to support FSSAI and Ayush submissions.
